Missed Meyer-Weigert duplex ureter during emergency ureteric stenting for ureteric stones
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Read our Cookies
Related Articles
Live Events
Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.
HF01-01 The “Exhibition of Living Patients”—Hutchinson, Ethics and Urology: Erratum | Journal of Urology
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
FDA greenlights phase 1 trial of theranostic radiopharmaceutical for mCRPC
The phase 1 study is set to begin later this year.
Monogenic Lupus Nephritis Signals Earlier Onset and Worse Renal Outcomes – Renal and Urology News
A team studied the differences between monogenic and nonmonogenic lupus nephritis and the predictors of end-stage kidney disease.
CHMP recommends EU approval of darolutamide plus ADT in mHSPC
The approval is supported by data from the pivotal phase 3 ARANOTE trial.
Amir Patel, MD, on onabotulinumtoxinA injection at the time of HoLEP
Amir S. Patel, MD, discusses interim findings from a randomized controlled trial of onabotulinumtoxinA injection at the time of HoLEP vs standard treatment.
2025 Fundamentals in Urology Lunch n’ Learn
🎙️ New to streaming or looking to level up? Check out StreamYard and get $10 discount! 😍 https://streamyard.com/pal/d/5406675905806336
Editorial Commentary | Urology Practice
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
Renal Hyperfiltration Trajectory Tied With Risk of ESKD, Cardiovascular Events, and Death – Renal and Urology News
Investigators studied whether changes in renal hyperfiltration status affects patient outcomes using a Korean population cohort of more than 4.5 million patients.
2025 Annual Meeting – Las Vegas
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence…